Clin2
NCT06071286Likely a fitRecruiting

Study tracking DNA from tumors in advanced ovarian cancer

Ovarian Cancer

Treatments studied

Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are newly diagnosed with advanced ovarian cancer (stage 3 or higher), or cancer of the fallopian tubes or lining of the abdomen.
  • You are between 18 and 80 years old.
  • You have not had any other cancer in the last 5 years.
  • You have not had chemotherapy or other targeted cancer treatments yet.
  • You are not pregnant or breastfeeding.
  • You are willing to sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06085404Recruiting
Growing lab-mini-tumors for ovarian cancer treatment choices

This trial uses a small piece of your cancer tissue (taken during surgery) to grow 'mini-tumors' in the lab. These help doctors find which treatments might work best for you. It is for people with advanced serous ovarian cancer.

Roma
NCT05030805Recruiting
Study maps ovarian cancer cells from surgical tissue

This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.

Strasbourg, Alsace
NCT05574673Recruiting
Study of DNA repair traits in ovarian cancer patients

This study looks at certain “DNA repair traits” (called homologous recombination phenotype) in people with epithelial ovarian cancer. Results may help researchers better understand who responds to platinum chemotherapy, which is commonly used for this cancer.

København Ø, Region Sjælland
NCT03010124Recruiting
Biomarker testing in ovarian cancer to guide future treatment

This study looks at tumor tissue from ovarian cancer patients to find “biomarkers,” or lab signals, that may predict how the disease behaves or how it might respond to treatment. You may be asked for a biopsy of the relapsed (coming back) tumor or to use an existing archived tumor sample.

Villejuif, Val de Marne
NCT06249308Recruiting
Liquid biopsy test for early ovarian cancer detection

This study is testing a blood test to see if it can catch ovarian cancer early. You may be eligible if you have been recently diagnosed with ovarian cancer and haven't started treatment yet.

Guangzhou, Guangdong
NCT06117384Recruiting
Personalized ovarian cancer treatment study

This study aims to use your tumor and blood samples to find the best treatment for your ovarian cancer. It may help tailor your care based on your unique cancer biology.

Helsinki

Hear when a new Ovarian cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.